🇺🇸 Anhydrovincaleukoblastine in United States

Anhydrovincaleukoblastine (anhydrovinblastine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Anhydrovincaleukoblastine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is Anhydrovincaleukoblastine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Anhydrovincaleukoblastine in United States?

Roswell Park Cancer Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.